Germany
Japan
United Kingdom
China
Rabbit Polyclonal Anti-ACTB Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ACTB |
TA349205 is a possible alternative to TA349208.
Antibodies
View as table Download
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Rabbit Polyclonal GATA3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | GATA3 antibody was raised against a 17 amino acid synthetic peptide near the carboxy terminus of human GATA3. The immunogen is located within amino acids 340 - 390 of GATA3. |
Rabbit anti-STAT5A (Phospho-Tyr694) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT5A around the phosphorylation site of tyrosine 694 (D-G-YP-V-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Rabbit polyclonal c-Jun (Phospho-Ser63) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human c-Jun around the phosphorylation site of Serine 63. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against WIF1 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This WIF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-80 amino acids from the N-terminal region of human WIF1. |
Rabbit polyclonal STAT5B (Ser731) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human STAT5B around the phosphorylation site of serine 731 (A-P-SP-P-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal AKT1/2/3 (Ab-315/316/312) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human AKT1/2/3 around the phosphorylation site of tyrosine 315/316/312 (P-E-YP-L-A). |
Rabbit polyclonal Integrin beta1 (Thr789) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Integrin β1 around the phosphorylation site of threonine 789 (V-T-TP-V-V). |
| Modifications | Phospho-specific |
Rabbit polyclonal Smad1 (Ser465) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Smad1 around the phosphorylation site of serine 465 (I-S-S-V-SP) |
| Modifications | Phospho-specific |
Rabbit polyclonal Smad1 (Ab-465) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Smad1 around the phosphorylation site of serine 465 (I-S-S-V-SP). |
Rabbit polyclonal Src (Tyr529) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Src around the phosphorylation site of tyrosine 529 (P-Q-YP-Q-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal C/EBP-a (Ser21) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human C/EBP-a around the phosphorylation site of serine 21 (L-Q-SP-P-P) |
| Modifications | Phospho-specific |
Rabbit polyclonal Akt (Thr450) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human AKT1 around the phosphorylation site of threonine 450 (T-I-TP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal CK-1a (Tyr294) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CK-1a around the phosphorylation site of tyrosine 294 (Y-D-YP-T-F). |
| Modifications | Phospho-specific |
Rabbit polyclonal STAT5B (Ab-731) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human STAT5B around the phosphorylation site of serine 731(A-P-S-P-A). |
Rabbit polyclonal c-Jun (Phospho-Ser243) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human c-Jun around the phosphorylation site of serine 243 (P-L-SP-P-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal c-Jun (Ab-170) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human c-Jun around the phosphorylation site of Tyrosine 170. |
Active filters
Reactivities
- Rat
Applications
- IHC
Clonalities
- Polyclonal
Families
- ES Cell Differentiation/IPS
Availabilities
- In Stock
Filter by
Category
Target Symbol
- AKT1 (8)
- GCG (4)
- JUN (4)
- SRC (4)
- STAT5B (4)
- CSNK1A1 (3)
- HNF1B (3)
- PRKCA (3)
- ACTB (2)
- AKT3 (2)
- ALDH1A1 (2)
- ANGPT1 (2)
- BDNF (2)
- BSG (2)
- CASP3 (2)
- CD93 (2)
- CDH1 (2)
- CEBPA (2)
- CSNK2A1 (2)
- CTNNB1 (2)
- CYP3A4 (2)
- EGF (2)
- FGF7 (2)
- FN1 (2)
- GATA6 (2)
- HCRTR1 (2)
- ID2 (2)
- MAP2 (2)
- MAPK8 (2)
- NOTCH1 (2)
- PDX1 (2)
- PLAU (2)
- SERPINA1 (2)
- SFRP1 (2)
- SHH (2)
- SMAD1 (2)
- SMAD5 (2)
- SP1 (2)
- TCF3 (2)
- TEK (2)
- TUBB3 (2)
- YBX1 (2)
- A1BG (1)
- ACE (1)
- ACTN1 (1)
- ACVR1 (1)
- AKT2 (1)
- ALCAM (1)
- ANGPTL2 (1)
- ANPEP (1)
- APH1A (1)
- AXIN1 (1)
- BGLAP (1)
- CCN1 (1)
- CCN3 (1)
- CD44 (1)
- CD69 (1)
- CEBPB (1)
- CHRDL1 (1)
- CSF3R (1)
- CST3 (1)
- CXCR4 (1)
- DLX5 (1)
- ENPEP (1)
- FGF18 (1)
- FGF4 (1)
- FLT3 (1)
- FOXA1 (1)
- GAPDH (1)
- GATA3 (1)
- GDF3 (1)
- GDF9 (1)
- GFAP (1)
- GLP1R (1)
- HGF (1)
- ICAM1 (1)
- ID3 (1)
- ID4 (1)
- IGFBP1 (1)
- IL2RA (1)
- INS (1)
- ITGAL (1)
- ITGAM (1)
- ITGB1 (1)
- ITGB3 (1)
- JAG1 (1)
- KDR (1)
- KLF4 (1)
- KRT7 (1)
- L1CAM (1)
- LDLR (1)
- LEF1 (1)
- MAPK3 (1)
- MAPK6 (1)
- MAPK9 (1)
- NCAM1 (1)
- NEUROG1 (1)
- PDGFC (1)
- PIM1 (1)
- PTPRC (1)
Antibody Hosts
Conjugates
Modifications
Pathways
- Pathways in cancer (53)
- Focal adhesion (41)
- ErbB signaling pathway (33)
- MAPK signaling pathway (32)
- Colorectal cancer (25)
- Tight junction (25)
- Wnt signaling pathway (23)
- Acute myeloid leukemia (22)
- Melanoma (22)
- Neurotrophin signaling pathway (21)
- Endometrial cancer (20)
- Jak-STAT signaling pathway (20)
- VEGF signaling pathway (20)
- Prostate cancer (19)
- Toll-like receptor signaling pathway (19)
- Fc epsilon RI signaling pathway (18)
- Regulation of actin cytoskeleton (18)
- Renal cell carcinoma (18)
- T cell receptor signaling pathway (18)
- Chemokine signaling pathway (17)
- Chronic myeloid leukemia (17)
- Glioma (17)
- Non-small cell lung cancer (17)
- Pancreatic cancer (17)
- B cell receptor signaling pathway (16)
- Fc gamma R-mediated phagocytosis (16)
- Insulin signaling pathway (16)
- Progesterone-mediated oocyte maturation (16)
- Adherens junction (15)
- Adipocytokine signaling pathway (15)
- GnRH signaling pathway (15)
- Leukocyte transendothelial migration (15)
- Small cell lung cancer (14)
- Apoptosis (13)
- Epithelial cell signaling in Helicobacter pylori infection (13)
- Gap junction (13)
- mTOR signaling pathway (13)
- Pathogenic Escherichia coli infection (12)
- TGF-beta signaling pathway (12)
- Cell adhesion molecules (CAMs) (11)
- Cytokine-cytokine receptor interaction (11)
- Endocytosis (11)
- Hematopoietic cell lineage (9)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (8)
- Metabolic pathways (8)
- Natural killer cell mediated cytotoxicity (8)
- Basal cell carcinoma (7)
- Melanogenesis (7)
- Type II diabetes mellitus (7)
- ECM-receptor interaction (6)
- Hedgehog signaling pathway (6)
- Huntington's disease (6)
- Hypertrophic cardiomyopathy (HCM) (6)
- Maturity onset diabetes of the young (6)
- Thyroid cancer (6)
- Viral myocarditis (6)
- Alzheimer's disease (5)
- Bladder cancer (5)
- Dilated cardiomyopathy (5)
- Vibrio cholerae infection (5)
- Axon guidance (4)
- Complement and coagulation cascades (4)
- Long-term depression (4)
- Long-term potentiation (4)
- NOD-like receptor signaling pathway (4)
- Notch signaling pathway (4)
- Prion diseases (4)
- Retinol metabolism (4)
- Vascular smooth muscle contraction (4)
- Calcium signaling pathway (3)
- Dorso-ventral axis formation (3)
- Neuroactive ligand-receptor interaction (3)
- Phosphatidylinositol signaling system (3)
- RIG-I-like receptor signaling pathway (3)
- Renin-angiotensin system (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Drug metabolism - cytochrome P450 (2)
- Drug metabolism - other enzymes (2)
- Linoleic acid metabolism (2)
- Metabolism of xenobiotics by cytochrome P450 (2)
- Oocyte meiosis (2)
- Parkinson's disease (2)
- Tyrosine metabolism (2)
- p53 signaling pathway (2)
- Autoimmune thyroid disease (1)
- Cardiac muscle contraction (1)
- Cysteine and methionine metabolism (1)
- Glutathione metabolism (1)
- Glycolysis / Gluconeogenesis (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Primary immunodeficiency (1)
- Regulation of autophagy (1)
- Systemic lupus erythematosus (1)
- Type I diabetes mellitus (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)